ORBIMED ADVISORS LLC

Insider Reports History

Location
New York, NY
Signature
/s/ Carl L. Gordon, Member of OrbiMed Advisors LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ORBIMED ADVISORS LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. 10%+ Owner Common Stock 5,599,842 $232,561,438 $41.53 12 Sep 2022 Indirect
Enliven Therapeutics, Inc. Director, 10%+ Owner Common Stock 7,663,349 $169,666,547 $22.14 16 May 2024 Indirect
Sionna Therapeutics, Inc. Director Common Stock 3,561,655 $158,671,730 $44.55 24 Dec 2025 Indirect
Verona Pharma plc Director Ordinary Shares 3,777,778 $75,555,560 $20.00 15 May 2023 Indirect
Third Harmonic Bio, Inc. Director, 10%+ Owner Common Stock 5,779,071 $59,522,120 $10.30 19 Sep 2022 Indirect
NeuroPace Inc 10%+ Owner Common Stock 3,238,199 $51,616,892 $15.94 14 May 2025 Indirect
Prelude Therapeutics Inc Director, 10%+ Owner Common Stock 10,119,756 $38,151,480 $3.77 22 May 2023 Indirect
Corvus Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 7,165,006 $29,796,393 $4.16 27 Jun 2025 Indirect
89bio, Inc. 10%+ Owner Common Stock 1,829,436 $21,093,397 $11.53 26 Jan 2022 Indirect
TELA Bio, Inc. 10%+ Owner Common Stock 2,407,242 $10,928,879 $4.54 02 Jul 2024 Indirect
Venetian-1 Acquisition Corp. Director Common Stock 2,677,256 $10,709,024 $4.00 01 Nov 2024 Indirect
Disc Medicine, Inc. Director Common Stock 186,541 $10,093,734 $54.11 24 Mar 2025 Indirect
Edgewise Therapeutics, Inc. Director, 10%+ Owner Common Stock 443,792 $8,933,533 $20.13 03 Apr 2025 Indirect
MBX Biosciences, Inc. Director, 10%+ Owner Common Stock 747,887 $8,107,095 $10.84 18 Feb 2025 Indirect
PMV Pharmaceuticals, Inc. 10%+ Owner Common Stock 4,975,291 $7,562,442 $1.52 23 Oct 2025 Indirect
Terns Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 755,635 $7,556,350 $10.00 16 Jul 2024 Indirect
ArriVent Biopharma, Inc. Director, 10%+ Owner Common Stock 1,513,664 $5,524,874 $3.65 30 Jan 2024 Indirect
Adicet Bio, Inc. 10%+ Owner Common Stock 4,490,254 $4,490,254 $1.00 08 Oct 2025 Indirect
Acutus Medical, Inc. Director, 10%+ Owner Common Stock 1,677,361 $2,616,683 $1.56 19 Jul 2021 Indirect
Passage BIO, Inc. 10%+ Owner Common Stock 6,066,343 $2,001,893 $0.3300 26 Jun 2025 Indirect
Arcutis Biotherapeutics, Inc. 10%+ Owner Common Stock 415,142 $1,469,935 $3.54 24 Jun 2022 Indirect
Janux Therapeutics, Inc. Director Common Stock 231,098 $1,356,545 $5.87 29 Dec 2021 Indirect
Homology Medicines, Inc. Director, 10%+ Owner Common Stock 2,252,987 $1,286,681 $0.5711 25 Mar 2024 By OrbiMed Private Investments VII, LP
Galecto, Inc. 10%+ Owner Common Stock 1,510,375 $1,132,781 $0.7500 15 Aug 2023 Indirect
scPharmaceuticals Inc. 10%+ Owner Common Stock 252,858 $1,011,432 $4.00 13 Aug 2024 Indirect
Shattuck Labs, Inc. Director Common Stock 1,051,021 $911,970 $0.8677 25 Aug 2025 Indirect
Keros Therapeutics, Inc. Director Common Stock 45,057 $799,761 $17.75 21 Nov 2025 Indirect
ImageneBio, Inc. Director Common Stock 287,885 $716,833 $2.49 25 Jul 2025 Indirect
Traws Pharma, Inc. 10%+ Owner Common Stock 602,000 $282,940 $0.4700 16 Sep 2024 Indirect
Repare Therapeutics Inc. Director Common Stock 96,190 $233,261 $2.42 07 Sep 2021 Indirect
ALPINE IMMUNE SCIENCES, INC. Director Common Stock 0 $0 $6.33 18 May 2024 Indirect
ARS Pharmaceuticals, Inc. Director Common Stock 0 $0 $13.00 26 Aug 2024 Indirect
Compass Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 $0 $1.59 09 Apr 2025 Indirect
Kinnate Biopharma Inc. Director, 10%+ Owner Common Stock 0 $0 $2.59 03 Apr 2024 Indirect
Theseus Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 0 $0 $3.05 14 Feb 2024 Indirect
Turnstone Biologics Corp. Director Common Stock 0 $0 $0.3590 08 Aug 2025 Indirect
Xtant Medical Holdings, Inc. 10%+ Owner Common Stock 0 $0 $0.4200 10 Apr 2025 Indirect
Upstream Bio, Inc. Director, 10%+ Owner Common Stock 4,554,873 15 Oct 2024 Indirect
Shattuck Labs, Inc. Director Common Warrants (right to buy) 3,073,298 25 Aug 2025 Indirect
Shattuck Labs, Inc. Director Pre-Funded Warrants (right to buy) 2,022,277 25 Aug 2025 Indirect
Traws Pharma, Inc. 10%+ Owner Pre-Funded Warrant (right to buy) 96,348 29 Dec 2024 Indirect
Traws Pharma, Inc. 10%+ Owner Series A Warrant (right to buy) 96,348 29 Dec 2024 Indirect
ALPINE IMMUNE SCIENCES, INC. Director Warrant (Right to Buy) 0 11 Jan 2024 Indirect
ArriVent Biopharma, Inc. Director, 10%+ Owner Series A Preferred Stock 0 30 Jan 2024 Indirect
ArriVent Biopharma, Inc. Director, 10%+ Owner Series B Preferred Stock 0 30 Jan 2024 Indirect
Corvus Pharmaceuticals, Inc. Director, 10%+ Owner Common Warrants (right to buy) 0 27 Jun 2025 Indirect
MBX Biosciences, Inc. Director, 10%+ Owner Series A Convertible Preferred Stock 0 16 Sep 2024 By OrbiMed Private Investments VII, LP
MBX Biosciences, Inc. Director, 10%+ Owner Series B Convertible Preferred Stock 0 16 Sep 2024 By OrbiMed Private Investments VII, LP
MBX Biosciences, Inc. Director, 10%+ Owner Series C Convertible Preferred Stock 0 16 Sep 2024 By OrbiMed Genesis Master Fund, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Common Stock 0 $55.00 01 Jul 2022 Indirect
Sierra Oncology, Inc. Director, 10%+ Owner Series A Warrants 0 01 Jul 2022 Indirect
Sionna Therapeutics, Inc. Director Series B convertible preferred stock 0 10 Feb 2025 Indirect
Sionna Therapeutics, Inc. Director Series C convertible preferred stock 0 10 Feb 2025 Indirect
Third Harmonic Bio, Inc. Director, 10%+ Owner Series A-2 Preferred Stock 0 19 Sep 2022 Indirect
Third Harmonic Bio, Inc. Director, 10%+ Owner Series A-3 Preferred Stock 0 19 Sep 2022 Indirect
Third Harmonic Bio, Inc. Director, 10%+ Owner Series B Preferred Stock 0 19 Sep 2022 Indirect
Tricida, Inc. Director, 10%+ Owner Common Stock 0 25 Nov 2022 Indirect
Upstream Bio, Inc. Director, 10%+ Owner Series A redeemable convertible preferred stock 0 15 Oct 2024 Indirect
Upstream Bio, Inc. Director, 10%+ Owner Series B redeemable convertible preferred stock 0 15 Oct 2024 Indirect
Venetian-1 Acquisition Corp. Director Simple Agreement for Future Equity 0 01 Nov 2024 Indirect

Insider Reports Filed by ORBIMED ADVISORS LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SION Sionna Therapeutics, Inc. 24 Dec 2025 1 -$1,486,010 4 Director 29 Dec 2025, 20:44
SION Sionna Therapeutics, Inc. 17 Dec 2025 3 -$83,428 4 Director 19 Dec 2025, 19:29
SION Sionna Therapeutics, Inc. 24 Nov 2025 3 -$4,814,205 4 Director 26 Nov 2025, 18:45
KROS Keros Therapeutics, Inc. 21 Nov 2025 2 -$3,807,766 4 Director 18 Dec 2025, 16:34
PMVP PMV Pharmaceuticals, Inc. 23 Oct 2025 1 -$1,520,000 4 10%+ Owner 27 Oct 2025, 17:19
ACET Adicet Bio, Inc. 08 Oct 2025 2 +$5,000,000 4 10%+ Owner 10 Oct 2025, 20:06
PMVP PMV Pharmaceuticals, Inc. 10 Sep 2025 1 -$900,000 4 10%+ Owner 12 Sep 2025, 17:09
STTK Shattuck Labs, Inc. 25 Aug 2025 6 +$5,471,826 4 Director 02 Sep 2025, 21:52
STTK Shattuck Labs, Inc. 25 Aug 2025 0 $0 3 Director 02 Sep 2025, 21:48
TSBX Turnstone Biologics Corp. 08 Aug 2025 1 $0 4 Director 12 Aug 2025, 17:22
IKNA ImageneBio, Inc. 25 Jul 2025 1 +$208,191 4 Director 30 Jul 2025, 21:30
CRVS Corvus Pharmaceuticals, Inc. 27 Jun 2025 3 -$0.2552 4 Director, 10%+ Owner 01 Jul 2025, 21:23
PASG Passage BIO, Inc. 24 Jun 2025 3 -$197,239 4 10%+ Owner 26 Jun 2025, 17:10
NPCE NeuroPace Inc 14 May 2025 2 -$2,665,333 4 10%+ Owner 16 May 2025, 17:26
PASG Passage BIO, Inc. 24 Apr 2025 3 -$78,731 4 10%+ Owner 24 Apr 2025, 17:38
PASG Passage BIO, Inc. 15 Apr 2025 3 -$49,704 4 10%+ Owner 17 Apr 2025, 18:10
XTNT Xtant Medical Holdings, Inc. 10 Apr 2025 2 -$30,708,129 4 10%+ Owner 14 Apr 2025, 19:14
CMPX Compass Therapeutics, Inc. 09 Apr 2025 1 -$5,678,571 4 Director, 10%+ Owner 11 Apr 2025, 19:24
EWTX Edgewise Therapeutics, Inc. 03 Apr 2025 2 +$10,000,000 4 Director, 10%+ Owner 04 Apr 2025, 19:33
IRON Disc Medicine, Inc. 24 Mar 2025 3 -$310,483 4 Director 26 Mar 2025, 19:00
IRON Disc Medicine, Inc. 19 Mar 2025 9 -$2,831,987 4 Director 21 Mar 2025, 20:00
IRON Disc Medicine, Inc. 10 Mar 2025 15 -$16,965,596 4 Director 12 Mar 2025, 21:34
MBX MBX Biosciences, Inc. 14 Feb 2025 4 +$2,020,756 4 Director, 10%+ Owner 19 Feb 2025, 17:52
SION Sionna Therapeutics, Inc. 10 Feb 2025 4 +$9,900,000 4 Director 10 Feb 2025, 16:28
SION Sionna Therapeutics, Inc. 06 Feb 2025 0 $0 3 Director 06 Feb 2025, 21:18
PASG Passage BIO, Inc. 10 Jan 2025 3 -$142,223 4 10%+ Owner 14 Jan 2025, 17:17
PASG Passage BIO, Inc. 06 Jan 2025 3 -$103,306 4 10%+ Owner 08 Jan 2025, 18:09
TRAW Traws Pharma, Inc. 29 Dec 2024 2 $0 4 10%+ Owner 27 Jan 2025, 19:03
PASG Passage BIO, Inc. 20 Dec 2024 1 -$138,193 4 10%+ Owner 26 Dec 2024, 16:34
PASG Passage BIO, Inc. 09 Dec 2024 3 -$51,988 4 10%+ Owner 11 Dec 2024, 17:32
PASG Passage BIO, Inc. 04 Dec 2024 2 -$77,338 4 10%+ Owner 06 Dec 2024, 19:07
NONE Lomond Therapeutics Holdings, Inc. 01 Nov 2024 13 +$9,999,997 4 Director 05 Nov 2024, 18:02
NONE Lomond Therapeutics Holdings, Inc. 01 Nov 2024 0 $0 3 Director 05 Nov 2024, 17:57
UPB Upstream Bio, Inc. 15 Oct 2024 8 +$14,025,000 4 Director, 10%+ Owner 17 Oct 2024, 16:17
UPB Upstream Bio, Inc. 10 Oct 2024 0 $0 3 Director, 10%+ Owner 10 Oct 2024, 20:09
PASG Passage BIO, Inc. 19 Sep 2024 1 -$27,903 4 10%+ Owner 23 Sep 2024, 16:51
TRAW Traws Pharma, Inc. 16 Sep 2024 0 $0 3 10%+ Owner 23 Sep 2024, 16:42
PASG Passage BIO, Inc. 16 Sep 2024 3 -$146,727 4 10%+ Owner 18 Sep 2024, 18:38
MBX MBX Biosciences, Inc. 16 Sep 2024 7 +$12,000,000 4 Director, 10%+ Owner 17 Sep 2024, 20:13
MBX MBX Biosciences, Inc. 12 Sep 2024 0 $0 3 Director, 10%+ Owner 12 Sep 2024, 19:14
SPRY ARS Pharmaceuticals, Inc. 26 Aug 2024 1 -$1,088,035 4 Director 28 Aug 2024, 16:26
SPRY ARS Pharmaceuticals, Inc. 21 Aug 2024 4 -$11,497,963 4 Director 23 Aug 2024, 18:38
KROS Keros Therapeutics, Inc. 13 Aug 2024 2 -$11,002,500 4 Director 15 Aug 2024, 17:01
SCPH scPharmaceuticals Inc. 13 Aug 2024 2 +$2,000,000 4 10%+ Owner 15 Aug 2024, 16:51
TERN Terns Pharmaceuticals, Inc. 15 Jul 2024 6 -$561,640 4 Director, 10%+ Owner 17 Jul 2024, 20:48
TELA TELA Bio, Inc. 28 Jun 2024 3 -$2,022,000 4 10%+ Owner 02 Jul 2024, 16:54
IRON Disc Medicine, Inc. 17 Jun 2024 3 +$3,000,024 4 Director 20 Jun 2024, 17:19
ALPN ALPINE IMMUNE SCIENCES, INC. 18 May 2024 2 $0 4 Director 20 May 2024, 19:47
ELVN Enliven Therapeutics, Inc. 16 May 2024 2 -$22,877,262 4 Director, 10%+ Owner 20 May 2024, 17:00
CRVS Corvus Pharmaceuticals, Inc. 06 May 2024 2 +$2,499,856 4 Director, 10%+ Owner 08 May 2024, 20:28
NPCE NeuroPace Inc 01 May 2024 3 -$409,426 4 10%+ Owner 03 May 2024, 17:16
NPCE NeuroPace Inc 24 Apr 2024 1 -$25,041 4 10%+ Owner 26 Apr 2024, 17:01
NPCE NeuroPace Inc 19 Apr 2024 3 -$913,057 4 10%+ Owner 23 Apr 2024, 18:38
NPCE NeuroPace Inc 16 Apr 2024 3 -$238,231 4 10%+ Owner 18 Apr 2024, 17:10
NPCE NeuroPace Inc 11 Apr 2024 2 -$7,026,033 4 10%+ Owner 15 Apr 2024, 17:25
KNTE Kinnate Biopharma Inc. 03 Apr 2024 5 $0 4 Director, 10%+ Owner 05 Apr 2024, 16:33
TRAW Traws Pharma, Inc. 01 Apr 2024 0 $0 3/A Other* 12 Apr 2024, 16:11
TRAW Onconova Therapeutics, Inc. 01 Apr 2024 0 $0 3 10%+ Owner 03 Apr 2024, 19:56
QTTB Homology Medicines, Inc. 25 Mar 2024 0 $0 3 Director, 10%+ Owner 27 Mar 2024, 17:17
THRX Theseus Pharmaceuticals, Inc. 14 Feb 2024 2 $0 4 Director, 10%+ Owner 14 Feb 2024, 16:02
AVBP ArriVent Biopharma, Inc. 30 Jan 2024 10 +$7,999,992 4 Director, 10%+ Owner 31 Jan 2024, 16:12
ACET Adicet Bio, Inc. 25 Jan 2024 3 +$7,500,000 4 Director, 10%+ Owner 26 Jan 2024, 19:14
AVBP ArriVent Biopharma, Inc. 25 Jan 2024 0 $0 3 Director, 10%+ Owner 25 Jan 2024, 20:40
EWTX Edgewise Therapeutics, Inc. 23 Jan 2024 1 +$4,999,995 4 Director, 10%+ Owner 25 Jan 2024, 16:28
ALPN ALPINE IMMUNE SCIENCES, INC. 11 Jan 2024 2 +$1,850,498 4 Director 16 Jan 2024, 16:39
ALPN ALPINE IMMUNE SCIENCES, INC. 27 Dec 2023 6 -$28,671,734 4 Director 29 Dec 2023, 16:18
IRON Disc Medicine, Inc. 18 Dec 2023 3 -$36,618 4 Director 20 Dec 2023, 18:28
IRON Disc Medicine, Inc. 14 Dec 2023 3 -$24,584,100 4 Director 15 Dec 2023, 18:04
IRON Disc Medicine, Inc. 12 Dec 2023 8 -$7,902,266 4 Director 14 Dec 2023, 17:44
PMVP PMV Pharmaceuticals, Inc. 22 Nov 2023 1 -$195,763 4 10%+ Owner 24 Nov 2023, 16:38
NPCE NeuroPace Inc 02 Oct 2023 2 -$75,449 4 10%+ Owner 04 Oct 2023, 17:36
SPRY ARS Pharmaceuticals, Inc. 29 Aug 2023 1 +$3,100,000 4 Director 31 Aug 2023, 17:26
GLTO Galecto, Inc. 15 Aug 2023 3 -$617,010 4 10%+ Owner 17 Aug 2023, 16:40
IKNA Ikena Oncology, Inc. 04 Aug 2023 2 $0 4/A Director 21 Sep 2023, 17:02
GLTO Galecto, Inc. 31 Jul 2023 3 -$628,200 4 10%+ Owner 02 Aug 2023, 17:05
GLTO Galecto, Inc. 25 Jul 2023 3 -$114,464 4 10%+ Owner 27 Jul 2023, 16:28
TSBX Turnstone Biologics Corp. 20 Jul 2023 6 +$4,999,992 4 Director, 10%+ Owner 24 Jul 2023, 16:38
TSBX Turnstone Biologics Corp. 20 Jul 2023 0 $0 3 Director, 10%+ Owner 20 Jul 2023, 21:45
THRX Theseus Pharmaceuticals, Inc. 17 Jul 2023 2 +$1,463,793 4 Director, 10%+ Owner 19 Jul 2023, 16:15
GLTO Galecto, Inc. 13 Jul 2023 3 -$467,280 4 10%+ Owner 17 Jul 2023, 16:13
ACET Adicet Bio, Inc. 27 Jun 2023 4 +$1,828,750 4 Director, 10%+ Owner 29 Jun 2023, 16:46
PASG Passage BIO, Inc. 27 Jun 2023 2 +$1,001,765 4 10%+ Owner 29 Jun 2023, 16:42
PRLD Prelude Therapeutics Inc 22 May 2023 1 +$4,999,999 4 Director, 10%+ Owner 24 May 2023, 17:09
ELVN Enliven Therapeutics, Inc. 17 May 2023 2 +$9,095 4 Director, 10%+ Owner 19 May 2023, 16:19
VRNA Verona Pharma plc 11 May 2023 4 -$9,938,132 4 Director 15 May 2023, 18:07
KNTE Kinnate Biopharma Inc. 04 May 2023 5 +$4,086,235 4 Director, 10%+ Owner 08 May 2023, 17:22
KNTE Kinnate Biopharma Inc. 28 Apr 2023 9 +$3,673,901 4 Director, 10%+ Owner 02 May 2023, 21:34
TELA TELA Bio, Inc. 19 Apr 2023 3 -$1,792,326 4 10%+ Owner 21 Apr 2023, 17:08
GLTO Galecto, Inc. 13 Apr 2023 9 -$128,257 4 10%+ Owner 17 Apr 2023, 17:28
GLTO Galecto, Inc. 10 Apr 2023 9 -$121,357 4 10%+ Owner 12 Apr 2023, 18:44
GLTO Galecto, Inc. 05 Apr 2023 6 -$221,994 4 10%+ Owner 07 Apr 2023, 16:42
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 2 $0 4 Director, 10%+ Owner 27 Feb 2023, 19:30
KNTE Kinnate Biopharma Inc. 17 Feb 2023 2 $0 4 Director, 10%+ Owner 23 Feb 2023, 13:16
IRON Disc Medicine, Inc. 15 Feb 2023 3 +$2,500,008 4 Director, 10%+ Owner 17 Feb 2023, 15:43
IRON Disc Medicine, Inc. 29 Dec 2022 4 $0 4 Director, 10%+ Owner 03 Jan 2023, 20:26
IRON Disc Medicine, Inc. 29 Dec 2022 0 $0 3 Director, 10%+ Owner 03 Jan 2023, 20:22
TERN Terns Pharmaceuticals, Inc. 23 Dec 2022 1 +$1,000,000 4 Director, 10%+ Owner 28 Dec 2022, 16:57
VRNA Verona Pharma plc 22 Dec 2022 5 -$136,000,855 4 Director 27 Dec 2022, 16:38
SCPH scPharmaceuticals Inc. 25 Nov 2022 1 +$4,002,495 4 10%+ Owner 29 Nov 2022, 15:36
TCDA Tricida, Inc. 22 Nov 2022 3 -$2,205,635 4 Director, 10%+ Owner 25 Nov 2022, 19:13
CMPX Compass Therapeutics, Inc. 08 Nov 2022 1 +$1,290,420 4 Director, 10%+ Owner 10 Nov 2022, 15:44
THRX Theseus Pharmaceuticals, Inc. 07 Nov 2022 1 +$1,000,320 4 Director, 10%+ Owner 09 Nov 2022, 15:25
THRD Third Harmonic Bio, Inc. 19 Sep 2022 5 +$5,100,000 4 Director, 10%+ Owner 21 Sep 2022, 18:00
EWTX Edgewise Therapeutics, Inc. 16 Sep 2022 1 +$4,999,999 4 Director, 10%+ Owner 16 Sep 2022, 16:31
THRD Third Harmonic Bio, Inc. 14 Sep 2022 0 $0 3 Director, 10%+ Owner 14 Sep 2022, 18:11
SWTX SpringWorks Therapeutics, Inc. 12 Sep 2022 2 -$4,919,148 4 10%+ Owner 14 Sep 2022, 16:24
TERN Terns Pharmaceuticals, Inc. 16 Aug 2022 6 +$8,929,800 4 Director, 10%+ Owner 18 Aug 2022, 17:00
XTNT Xtant Medical Holdings, Inc. 15 Aug 2022 2 $0 4 Director, 10%+ Owner 17 Aug 2022, 16:31
SWTX SpringWorks Therapeutics, Inc. 08 Aug 2022 2 -$10,464,363 4 10%+ Owner 10 Aug 2022, 16:22
SRRA Sierra Oncology, Inc. 01 Jul 2022 6 -$108,062,350 4 Director, 10%+ Owner 01 Jul 2022, 16:50
ARQT Arcutis Biotherapeutics, Inc. 24 Jun 2022 2 -$7,287,402 4 10%+ Owner 28 Jun 2022, 16:29
IKNA Ikena Oncology, Inc. 22 Jun 2022 4 -$1,128,021 4 Director 24 Jun 2022, 17:39
PMVP PMV Pharmaceuticals, Inc. 26 May 2022 1 -$418,210 4 10%+ Owner 31 May 2022, 16:36
EWTX Edgewise Therapeutics, Inc. 18 May 2022 1 +$994,980 4 Director, 10%+ Owner 20 May 2022, 16:38
CMPX Compass Therapeutics, Inc. 11 May 2022 3 +$420,482 4 Director, 10%+ Owner 13 May 2022, 17:45
CMPX Compass Therapeutics, Inc. 06 May 2022 3 +$197,252 4 Director, 10%+ Owner 10 May 2022, 18:21
PASG Passage BIO, Inc. 03 May 2022 2 +$1,016,285 4 10%+ Owner 05 May 2022, 17:23
ARQT Arcutis Biotherapeutics, Inc. 06 Apr 2022 6 -$18,163,608 4 10%+ Owner 08 Apr 2022, 18:06
PMVP PMV Pharmaceuticals, Inc. 29 Mar 2022 3 -$10,264,415 4 10%+ Owner 31 Mar 2022, 17:30
KNTE Kinnate Biopharma Inc. 11 Feb 2022 4 +$1,989,446 4 Director 15 Feb 2022, 20:42
SRRA Sierra Oncology, Inc. 26 Jan 2022 6 +$6,434,340 4 Director, 10%+ Owner 28 Jan 2022, 20:22
ETNB 89bio, Inc. 25 Jan 2022 4 -$592,384 4 10%+ Owner 27 Jan 2022, 16:22
PASG Passage BIO, Inc. 20 Jan 2022 1 +$254,000 4/A 10%+ Owner 05 May 2022, 17:11
THRX Theseus Pharmaceuticals, Inc. 19 Jan 2022 3 +$1,578,717 4 Director, 10%+ Owner 21 Jan 2022, 18:18
PASG Passage BIO, Inc. 14 Jan 2022 3 +$905,205 4 10%+ Owner 20 Jan 2022, 17:03
PASG Passage BIO, Inc. 11 Jan 2022 3 +$841,082 4 10%+ Owner 13 Jan 2022, 18:37
THRX Theseus Pharmaceuticals, Inc. 11 Jan 2022 4 +$442,750 4 Director, 10%+ Owner 13 Jan 2022, 18:18
JANX Janux Therapeutics, Inc. 29 Dec 2021 2 -$820,120 4 Director 30 Dec 2021, 20:00
JANX Janux Therapeutics, Inc. 21 Dec 2021 2 -$2,268,600 4 Director 23 Dec 2021, 15:13
JANX Janux Therapeutics, Inc. 16 Dec 2021 2 -$7,500,231 4 Director 17 Dec 2021, 16:13
ACET Adicet Bio, Inc. 10 Dec 2021 1 +$2,999,990 4 Director, 10%+ Owner 14 Dec 2021, 17:41
TCDA Tricida, Inc. 15 Nov 2021 2 +$4,000,002 4 Director, 10%+ Owner 17 Nov 2021, 15:09
CMPX Compass Therapeutics, Inc. 04 Nov 2021 2 +$18,750,000 4 Director, 10%+ Owner 08 Nov 2021, 20:06
THRX Theseus Pharmaceuticals, Inc. 12 Oct 2021 7 +$10,000,000 4 Director, 10%+ Owner 14 Oct 2021, 17:00
THRX Theseus Pharmaceuticals, Inc. 06 Oct 2021 0 $0 3 Director, 10%+ Owner 06 Oct 2021, 19:00
CRVS Corvus Pharmaceuticals, Inc. 20 Sep 2021 1 -$6,757,732 4 Director, 10%+ Owner 22 Sep 2021, 17:27
ALPN ALPINE IMMUNE SCIENCES, INC. 17 Sep 2021 2 +$9,499,988 4 Director, 10%+ Owner 21 Sep 2021, 18:42
RPTX Repare Therapeutics Inc. 03 Sep 2021 4 -$274,794 4 Director 08 Sep 2021, 18:18
RPTX Repare Therapeutics Inc. 31 Aug 2021 6 -$1,290,550 4 Director 02 Sep 2021, 20:27
RPTX Repare Therapeutics Inc. 26 Aug 2021 6 -$615,748 4 Director 30 Aug 2021, 18:37
RPTX Repare Therapeutics Inc. 23 Aug 2021 6 -$622,426 4 Director 25 Aug 2021, 20:43
RPTX Repare Therapeutics Inc. 17 Aug 2021 4 -$693,210 4 Director 19 Aug 2021, 20:55
XTNT Xtant Medical Holdings, Inc. 15 Aug 2021 2 $0 4 Director, 10%+ Owner 17 Aug 2021, 17:58
AFIB Acutus Medical, Inc. 19 Jul 2021 2 +$14,999,992 4 Director, 10%+ Owner 21 Jul 2021, 17:30
ELVN IMARA Inc. 16 Jul 2021 1 +$9,999,996 4/A Director, 10%+ Owner 23 Jul 2021, 17:30
SWTX SpringWorks Therapeutics, Inc. 01 Jul 2021 1 -$1,356,675 4 10%+ Owner 06 Jul 2021, 16:42
SWTX SpringWorks Therapeutics, Inc. 28 Jun 2021 1 -$553,775 4 10%+ Owner 30 Jun 2021, 21:01
SWTX SpringWorks Therapeutics, Inc. 23 Jun 2021 3 -$4,824,541 4 10%+ Owner 25 Jun 2021, 19:11
JANX Janux Therapeutics, Inc. 15 Jun 2021 8 +$11,999,501 4 Director 16 Jun 2021, 18:17
SWTX SpringWorks Therapeutics, Inc. 10 Jun 2021 1 -$2,625,197 4 10%+ Owner 14 Jun 2021, 17:58
JANX Janux Therapeutics, Inc. 10 Jun 2021 0 $0 3 Director 10 Jun 2021, 19:35
SWTX SpringWorks Therapeutics, Inc. 07 Jun 2021 3 -$4,101,908 4 10%+ Owner 09 Jun 2021, 18:26